DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,104 filers reported holding DANAHER CORPORATION in Q4 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,010,793 | +5.4% | 8,048 | +5.3% | 0.02% | 0.0% |
Q1 2024 | $1,908,360 | +133.0% | 7,642 | +115.8% | 0.02% | +110.0% |
Q4 2023 | $819,124 | -7.8% | 3,541 | -1.1% | 0.01% | -23.1% |
Q3 2023 | $888,694 | +5.5% | 3,582 | +2.1% | 0.01% | +8.3% |
Q2 2023 | $842,160 | +5.7% | 3,509 | +11.0% | 0.01% | -7.7% |
Q1 2023 | $796,950 | -12.1% | 3,162 | -7.4% | 0.01% | -18.8% |
Q4 2022 | $906,409 | +6.8% | 3,415 | +3.9% | 0.02% | -5.9% |
Q3 2022 | $849,000 | +14.6% | 3,286 | +12.4% | 0.02% | +21.4% |
Q2 2022 | $741,000 | +0.1% | 2,924 | +15.8% | 0.01% | +16.7% |
Q1 2022 | $740,000 | -5.0% | 2,524 | +6.5% | 0.01% | 0.0% |
Q4 2021 | $779,000 | +30.9% | 2,369 | +21.1% | 0.01% | +20.0% |
Q3 2021 | $595,000 | +8.2% | 1,956 | -4.6% | 0.01% | +11.1% |
Q2 2021 | $550,000 | +22.8% | 2,051 | +3.1% | 0.01% | 0.0% |
Q1 2021 | $448,000 | -4.9% | 1,989 | -6.2% | 0.01% | -18.2% |
Q4 2020 | $471,000 | -1.3% | 2,121 | -4.3% | 0.01% | -8.3% |
Q3 2020 | $477,000 | +32.1% | 2,216 | +8.5% | 0.01% | +20.0% |
Q2 2020 | $361,000 | +27.6% | 2,042 | 0.0% | 0.01% | 0.0% |
Q1 2020 | $283,000 | -12.7% | 2,042 | -3.4% | 0.01% | +11.1% |
Q4 2019 | $324,000 | – | 2,114 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |